Table 2.
Assumption | |
---|---|
Similarity | Are the studies included in the NMA similar enough in terms of research question (PICOS) to be pooled together? |
Transitivity | Are there any effect modifiers (patient or study characteristics) known or thought to influence the treatment effect? If so, are there no systematic differences in the distribution of effect modifiers between the included trials? |
Consistency | For mixed comparisons, is there agreement between the direct (head-to-head) and indirect (via a common comparator) evidence within the network? |
Homogeneity | Are there no imbalances in population, interventions, outcomes, or study design across direct and indirect comparisons within the NMA? |
NMA network meta-analysis; PICOS population, intervention, comparator, outcome, setting